|Avita Medical Limited -- USA Stock|| |
USD 1.02 0.02 1.92%
Mr. Troy A. Barring is Chief Operating Officer of the Company. Barring has a particular brief to support the implementation of Avitas 53.9m contract with BARDA, a US federal agency that prepares for potential disasters. The contract supports various company activities in advance of a US launch, and Barring will oversee the plan to strengthen regulatory, quality, and supply chain functions. He will also manage other key operational aspects of the Company, to support its global commercialisation activities in territories where it is already inmarket.
COO Since 2016
44 1763 269770 http://www.avitamedical.com
The company has return on total asset (ROA)
of (97.34) %
which means that it has lost $97.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (192.26) %
meaning that it generated substantial loss on money invested by shareholders.
Avita Medical Limited, a regenerative medicine company, develops and distributes regenerative solutions for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Avita Medical Limited (AVMXY) is traded on OTC Market in USA. It is located in Royston, SG HB and employs 26 people.